Find information and resources about the Research Institute's COVID-19 response
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Research in the Abdulmalik Laboratory focuses on the development of novel therapies for the hemoglobinopathies, with a particular emphasis on developing and validating novel therapeutic agents for sickle cell disease.
